Zai Lab (ZLAB), a $3.3B market cap Chinese pharmaceutical company, is growing revenues at 40%+ and positioned to benefit from the country’s rapidly aging demographics. With China expected to undergo a ...
- Investor conference call and webcast to discuss data and clinical trial plans on June 2, 2025, at 7:00 a.m. CT / 8:00 a.m. ET / 8:00 p.m. HKT SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback